Juliana M. Reed, executive director of the Biosimilars Forum, released the following statement following the FDA’s formal issuance of new draft guidance—accompanied by a press release and fact sheet—on bringing lower-cost biosimilar drugs to Americans that need them.
Lower-Cost, Safe and Effective Biosimilars
Comment
Show comments
Hide Comments
